In parallel, patients’ data were analyzed and showed that TXNIP is highly expressed in T lymphocytes and that its expression is reduced in tumor-infiltrating CD4+ T cells compared to those in paired normal adjacent tissue and blood. This evidence concerns the gene CD4 and neoplasm.